Author Agata Marjańska
ORIGINAL PAPER
Therapy with selumetinib in children with neurofibromatosis type 1 in Poland – clinical experience of the first year of the national program
Jagoda Styczyńska, Agata Marjańska, Agnieszka Jatczak-Gaca, Marek Karwacki, Justyna Walenciak, Katarzyna Garus, Katarzyna Bilska, Agnieszka Mizia-Malarz, Wanda Badowska, Dorota Sławińska, Jadwiga Węcławek-Tompol, Radosław Chaber, Ewa Bień, Grażyna Karolczyk, Jolanta Skalska-Sadowska, Jan Styczyński
Pediatr Pol 2025;61(4):328-331
CASE REPORT
Differential symptomatology and prevention of permanent complications dependent on localisation of osteochondroma
Przemysław Gałązka, Marika Reszczyńska-Domagała, Krzysztof Redloch, Przemysław Ratajczak, Agata Marjańska, Jan Styczyński, Irena Daniluk-Matraś
Pediatr Pol 2018;93(6):484-487
ORIGINAL PAPER
Pineal cysts as a cause of central nervous system symptoms
Pediatr Pol 2017;92(2):143-148
ORIGINAL PAPER
Evaluation of bone abnormalities in children with neurojibromatosis type 1
Anna Hagner, Agata Marjańska, Magdalena Dziedzic, Agnieszka Jatczak-Gaca, Jan Styczyński, Bartosz Romańczuk, Grażyna Odrowąż-Sypniewska, Mariusz Wysocki
Pediatr Pol 2017;92(6):675-680
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
